Compass Ion Advisors’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,000
Closed -$28K 75
2022
Q2
$28K Hold
15,000
0.01% 76
2022
Q1
$48K Hold
15,000
0.01% 89
2021
Q4
$65K Buy
+15,000
New +$81.1K 0.02% 95

Other funds holding CGEN

Compass Ion Advisors's CGEN Position: Q3 2022 in Review

Compass Ion Advisors sold out of Compugen (CGEN) in Q3 2022, closing a stake of 15,000 shares — an estimated $28K sold.

Compass Ion Advisors first reported a position in CGEN in Q4 2021 and held it in 3 quarters. The position peaked at $65K in Q4 2021. 81 funds tracked by Wall St. Rank hold CGEN as of Q3 2022.

  • Compass Ion Advisors reported no remaining Compugen position as of Q3 2022 after selling out during the quarter.
  • Compass Ion Advisors sold 15,000 Compugen shares in Q3 2022, an estimated $28K.
  • Compass Ion Advisors first reported a position in Compugen in Q4 2021 and held it in 3 quarters.
  • Compass Ion Advisors's Compugen position peaked at $65K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Compugen as of Q3 2022.

Based on Compass Ion Advisors's 13F filing for Q3 2022, filed 18 Oct 2022.